Tuesday, August 08, 2017 12:44:31 PM
You don't want to short something you can't cover, but stocks fail in the OTC all the time. DRYS has been a great example of that historically. R/S then short into the ground like clockwork.
On the other side, what I'm seeing on USRM chart is a near term historic low in price. You'll see about 6 months ago that they were trading at next to nothing, but as of the last 3 months have added and are holding value. The pop to .17 was clearly artificial, but they'd REALLY have to throw the game to go much lower than this with the current interest in stem cell tech. That said, the company still needs to provide investors with knowledge that USRM is doing well on the business side and making money. Severe losses would be unacceptable, and it appears that focusing profit was their big goal in dropping RMAT pursuit for the time being.
They need to innovate, advance AND profit. No point in being cutting edge if you can't make a buck.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM